SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-033527
Filing Date
2023-07-19
Accepted
2023-07-19 16:15:50
Documents
15
Period of Report
2023-07-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20230719.htm   iXBRL 8-K 65469
2 EX-10.1 srzn-ex10_1.htm EX-10.1 69003
3 GRAPHIC img176543089_0.jpg GRAPHIC 7155
  Complete submission text file 0000950170-23-033527.txt   312243

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20230719_lab.xml EX-101.LAB 17592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20230719_pre.xml EX-101.PRE 12994
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20230719_def.xml EX-101.DEF 13694
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20230719.xsd EX-101.SCH 3109
9 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20230719_htm.xml XML 6585
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 231096898
SIC: 2836 Biological Products, (No Diagnostic Substances)